Our findings suggest that the increase in PRMT1 expression in liver in obesity serves as a compensatory mechanism for the decrease in SAM to alleviate HFD-induced hepatic steatosis and liver damage by promoting fatty acid oxidation. Here, PRMT1 is linked to fatty liver disease.